CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Combates, N. J.
Right arrow Articles by Cohen, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Combates, N. J.
Right arrow Articles by Cohen, D.

Cell Growth & Differentiation, Vol 8, Issue 2 213-219, Copyright © 1997 by American Association of Cancer Research


ARTICLES

Involvement of the transcription factor NF-IL6 in phorbol ester induction of P-glycoprotein in U937 cells

NJ Combates, PO Kwon, RW Rzepka and D Cohen
Oncology Research Program, Sandoz Research Institute, East Hanover, New Jersey 07936, USA.

Previously, we showed that the nuclear factor NF-IL6 binds and trans-activates the promoter of the human multidrug resistance gene (MDR1) encoding P-glycoprotein (N. J. Combates et al., J. Biol. Chem., 269: 29715-29719, 1994). In this study, we investigated the physiological relevance of MDR1 gene regulation by NF-IL6 in response to PMA (phorbol 12-myristate 13-acetate)-induced differentiation. Treatment of U937 cells, a human promonocytic cell line, with PMA induced their differentiation along the macrophage/monocytic cell lineage. The cellular changes were found to be accompanied by an increase in P-glycoprotein expression at the cell surface. PMA treatment of U937 cells also resulted in the synthesis of the three forms of NF-IL6 and an enhanced DNA binding activity of nuclear extracts to a probe derived from the MDR1 promoter. The majority of the DNA-protein complex could be supershifted by an NF-IL6 reactive antibody but not by antibodies for CAAT/enhancer binding protein alpha and delta, c-fos, or c-jun. Furthermore, transient transfection studies demonstrated that PMA enhanced the activity of a MDR1 promoter-driven luciferase gene construct to a greater extent as compared with the activity of a reporter construct containing mutations within the NF-IL6 responsive element. These results indicate a correlation between NF-IL6 gene expression and the regulation of the MDR1 gene. Furthermore, these observations also suggest that P-glycoprotein expression is part of the macrophage differentiation process.


This article has been cited by other articles:


Home page
Cancer Res.Home page
L. Mickley Huff, Z. Wang, A. Iglesias, T. Fojo, and J.-S. Lee
Aberrant Transcription from an Unrelated Promoter Can Result in MDR-1 Expression following Drug Selection In vitro and in Relapsed Lymphoma Samples
Cancer Res., December 15, 2005; 65(24): 11694 - 11703.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
M. Kuwano, Y. Oda, H. Izumi, S.-J. Yang, T. Uchiumi, Y. Iwamoto, M. Toi, T. Fujii, H. Yamana, H. Kinoshita, et al.
The role of nuclear Y-box binding protein 1 as a global marker in drug resistance
Mol. Cancer Ther., November 1, 2004; 3(11): 1485 - 1492.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. M. Comerford, T. J. Wallace, J. Karhausen, N. A. Louis, M. C. Montalto, and S. P. Colgan
Hypoxia-inducible Factor-1-dependent Regulation of the Multidrug Resistance (MDR1) Gene
Cancer Res., June 1, 2002; 62(12): 3387 - 3394.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Conze, L. Weiss, P. S. Regen, A. Bhushan, D. Weaver, P. Johnson, and M. Rincon
Autocrine Production of Interleukin 6 Causes Multidrug Resistance in Breast Cancer Cells
Cancer Res., December 1, 2001; 61(24): 8851 - 8858.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J.-M. Yang, A. D. Vassil, and W. N. Hait
Activation of Phospholipase C Induces the Expression of the Multidrug Resistance (MDR1) Gene through the Raf-MAPK Pathway
Mol. Pharmacol., October 1, 2001; 60(4): 674 - 680.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
V. K. Harris, E. D. E. Liaudet-Coopman, B. J. Boyle, A. Wellstein, and A. T. Riegel
Phorbol Ester-induced Transcription of a Fibroblast Growth Factor-binding Protein Is Modulated by a Complex Interplay of Positive and Negative Regulatory Promoter Elements
J. Biol. Chem., July 24, 1998; 273(30): 19130 - 19139.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
T. Ohga, T. Uchiumi, Y. Makino, K. Koike, M. Wada, M. Kuwano, and K. Kohno
Direct Involvement of the Y-box Binding Protein YB-1 in Genotoxic Stress-induced Activation of the Human Multidrug Resistance 1 Gene
J. Biol. Chem., March 13, 1998; 273(11): 5997 - 6000.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1997 by the American Association of Cancer Research.